A Phase I-II Study of Tesetaxel Plus Capecitabine and Cisplatin in Subjects With Advanced Gastric Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Capecitabine; Cisplatin; Tesetaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 29 Jun 2011 This trial is expected to be a 'run-in' for a planned phase III trial of tesetaxel first-line therapy in advanced gastric cancer, according to a Genta media release.
- 29 Jun 2011 Accrual at the first dosing level in phase I has been completed, according to a Genta media release.
- 13 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.